IPRIA Working Paper Series
|
Intellectual Property Research Institute of Australia Working Paper No. 08/2005 Intellectual Property Strategy and Business Strategy: Connections Through Innovation Strategy by Danny Sampson Date: June 2005 Abstract: “Polartechnics: The case study provides a qualitative analysis of best practice in intellectual property strategy and commercialisation at Polartechnics Limited. A case study protocol was developed and used to conduct a face-to-face interview with the company’s Principal Scientist. Polartechnics core business is to develop and commercialise instrumentation for the screening and detection of normal, pre-cancer and cancer conditions. The case study explores Polartechnics’ strategic view and practices around intellectual property by highlighting the strengths and challenges faced by the company in its pursuit of commercial success. The case study sets out the lessons learned. Applied Biosystems: The case study is based on the Australian arm of the multinational company Applied Biosystems. Applied Biosystems is a global biotechnology company with its main office in the United States. The company’s core business is to develop and commercialise instruments and reagents for the automated synthesis and analysis of biomolecules. A case study protocol was designed to gather the qualitative data by conducting face-to-face interviews with the company’s Managing Director and Product Development Manager. The case study identifies and explains how best practice in intellectual property is implemented for successfully commercialising product innovation. The case study explores Applied Biosystem’s strategic view and practices around intellectual property by highlighting the strengths and challenges faced by the company in this area in its pursuit of commercial success. Starpharma Limited: This case study highlights best practice in intellectual property strategy and practice for the successful commercialisation of innovation at Starpharma. A case study protocol was developed and used in a face-to-face interview with the company’s Intellectual Property Manager. Starpharma is an Australian biotechnology company whose core business is to develop and commercialise new pharmaceutical drugs based on innovation in the emerging field of dendrimer science. The case study explores Starpharma’s strategic view and practices around intellectual property by highlighting the strengths and challenges faced by the company in this area, in its pursuit of commercial success.” Downloads: PDF [326K] |
Search Again